US EditionCalifornia to begin selling affordable state-branded insulin beginning next year
California will sell insulin pens for $11 each starting in 2026, potentially saving patients $2,000 to $4,000 annually by bypassing major drug companies, officials said.
- California Governor Gavin Newsom announced the availability of insulin pens at $11 each starting January 1, 2026, as part of the state’s pharmaceutical initiative.
- This program aims to reduce insulin costs for the 3.5 million Californians with diabetes, according to the American Diabetes Association.
- Newsom stated that no Californian should have to ration insulin or go into debt for their health, emphasizing California's proactive approach to drug pricing.
- Senator Scott Wiener highlighted the importance of this legislation, ensuring families do not have to choose between medication and essential needs.
128 Articles
128 Articles
Newsom Says California Will Start Selling Its Own $11 Insulin Pens Next Year
California Gov. Gavin Newsom announced on Oct. 16 that the state would start selling its own brand of affordable insulin pens next year to improve access to essential medication across the state. The insulin pens will be sold under the state’s CalRx brand for $11 per pen or $55 per five-pack, with sales expected to begin on Jan. 1, 2026, according to a statement from the governor’s office. This follows an agreement reached by California with dru…
California takes on pharma giants with plans to sell its own insulin
After a three-year effort, California will start selling low-cost insulin pens this January, the first such move by a state to circumvent the pharmaceutical industry and combat diabetes. A pack of five pens will be made available for $55 through the CalRx program, which was initiated five years ago by California Gov. Gavin Newsom to bring less expensive medicines to state residents. The program contracts with companies to make generic drugs and,…
Governor Gavin Newsom said that since January 1, 2026, California residents will have access to insulin, at a cost of $11 per unit
Los Angeles, Oct 16 (EFE).- California will start selling low-cost insulin from its own brand as of January 1, 2026, making the state the first in the country to sell generic drugs produced with state investment. California’s governor, Democrat Gavin Newsom, announced this Thursday that from next year each CalRx insulin pen will start selling at $11. The announcement comes almost three years after California signed an agreement with Civica Rx, a…
Newsom Announces Affordable Insulin Soon to Be Available for Purchase
California has become the first and only state to make its own affordable insulin, with the medication expected to be available for purchase starting Jan. 1., Gov. Gavin Newsom announced in Los Angeles Thursday. Through a state-backed deal with Civica Rx, a nonprofit generic drug manufacturer, and Biocon Biologics, California residents will have access to an interchangeable biosimilar insulin glargine pen offered under the CalRx brand and pricin…
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
